I said "before" the DMC recommendation. I didnt say that would be the price following the recommendation of a halt. If a halt is recommended you will see it double from wherever it is on the eve of the recommendation. Let me be clear because there are far too many folk on this board with major deficiencies in basic reading and comprehension skills.....
I'll also write in bold capital letters for added clarity so that there is no abiguity here whatsoever.
THE 967PR IS THE STARTING GUN THAT SIGNALS THAT WE ARE OFF TO THE RACES. THE SHARE PRICE WILL SEE A POP ON THE BACK OF THE ANNOUNCEMENT. MY PREDICTION WOULD BE SOMEWHERE IN THE $3 RANGE.
THE STOCK PRICE WILL THEN SEE A NICE SPECULATIVE RUN-UP TOWARDS $10 IN THE 2-3 MONTH DMC ANALYSIS PERIOD.
IF THE RECOMMENDATION IS A HALT THE STOCK WILL DOUBLE FROM WHATEVER PRICE IT WAS AT BEFORE THE ANNOUNCEMENT. SO, IF IT IS AT $10 IT WILL DOUBLE TO $20.
THIS WILL THEN TRIGGER A WAVE OF SELLING BUT ALSO RENEWED ACCUMULATION AS THE STOCK WILL STILL BE UNDERVALUED AT $20. THIS WILL RESULT IN THE STOCK PRICE CONTINUING TO CLIMB UP AND OVER $30. MY OWN PERSONAL OPINION IS THAT >$40 IS VERY POSSIBLE.
IF THE DMC RECOMMEND A CONTINUATION OF THE TRIAL THE SHARE PRICE WILL TANK. IF IT IS AT $10 IT WILL BE BACK UNDER $5 WITHIN A WEEK OF THE ANNOUNCEMENT.
AMARIN WILL THEN DILUTE THE STOCK TO RAISE CAPITAL WHICH WILL SEE IT BACK DOWN AROUND THE $1 LEVELS. THIS IS THE POINT AT WHICH THE PROS WILL REACCUMULATE THE STOCK AND SO SHOULD YOU.
News 
Market Data 
Discover 
AI
